Drawing for QUINTILES

USPTO serial 75525974

QUINTILES

Reviewed by CopyMark Law Group

Reg. 2340026Status 704Registered
Filing date
Status date
Registration date
Apr 11, 2000
Examiner
SINGLETON, RUDY
Law office
GENERIC WEB UPDATE

What this means

Status 704 applies to Madrid Protocol extensions of protection in the U.S. Section 71 (similar to Section 8) showing continued use was accepted. The U.S. extension remains active. Follow Madrid and USPTO deadlines for the next renewal cycle.

Status 704: Status 704 applies to Madrid Protocol extensions of protection in the U.S. Section 71 (similar to Section 8) showing continued use was accepted. The U.S. extension remains active.

Need help with QUINTILES?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

ARLENE D. HANKS

ARLENE D. HANKS Moore & Van Allen PLLC100 North Tryon StreetSuite 4700Charlotte, NC 28202-4003

Goods and services

ClassDescriptionStatusFirst use
009[ Computer software for managing clinical trial data and information in the field of pharmaceutical, veterinary, pharmacogenomic, biotechnical and medical products and devices]SECTION 8 - CANCELLED—
035Computerized database management and data processing services in the fields of pharmaceutical, [ veterinary, ] pharmacogenomic, biotechnical and medical products and devices; [ manufacturers' sales representatives in the fields of pharmaceutical, veterinary, pharmacogenomic, biotechnical and medical products and devices;] business marketing and consulting services in the fields of pharmaceutical, [ veterinary, ] pharmacogenomic, biotechnical and medical products and devicesACTIVEFeb 1, 1992
042Clinical research and testing in the fields of pharmaceutical, [ veterinary, ] pharmacogenomic, biotechnical and medical products and devices; consultation services in the fields of pharmaceutical, [ veterinary, ] pharmacogenomic, biotechnical and medical products and devices; healthcare policy research and development services; laboratory testing services in the fields of pharmaceutical, [ veterinary, ] pharmacogenomic, biotechnical and medical products and devicesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 5, 2026ASCKASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY—
May 30, 2019NAS8NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED—
May 30, 2019NAS8NOTICE OF ACCEPTANCE OF SEC. 8 - MAILED—
May 30, 2019NAS8NOTICE OF ACCEPTANCE OF SEC. 8 - MAILED—
May 30, 2019NAS8NOTICE OF ACCEPTANCE OF SEC. 8 - MAILED—
May 30, 2019NAS8NOTICE OF ACCEPTANCE OF SEC. 8 - MAILED—
May 30, 2019CORVREVIEW OF CORRESPONDENCE COMPLETE - INFORMATION MADE OF RECORD—
May 30, 20198PRTREGISTERED - PARTIAL SEC. 8 (10-YR) ACCEPTED—
May 30, 20198PRTREGISTERED - PARTIAL SEC. 8 (10-YR) ACCEPTED—
May 30, 20198PRTREGISTERED - PARTIAL SEC. 8 (10-YR) ACCEPTED—
May 30, 20198PRTREGISTERED - PARTIAL SEC. 8 (10-YR) ACCEPTED—
May 30, 20198PRTREGISTERED - PARTIAL SEC. 8 (10-YR) ACCEPTED—
May 29, 2019NA89NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED—
May 29, 2019APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
May 29, 2019XXXXPOST REGISTRATION ACTION CORRECTION—
May 29, 2019APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Apr 25, 2019E89RTEAS SECTION 8 & 9 RECEIVED—
Apr 11, 2019REM2COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED—
Dec 18, 2018TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Oct 17, 2018ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Aug 1, 2018ASCKASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY—
Oct 19, 2016ASCKASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY—
Oct 12, 2016ASCKASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY—
May 27, 2015ASCKASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY—
May 20, 2015ASCKASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY—
Nov 17, 2014TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Apr 6, 2010XXXXPOST REGISTRATION ACTION CORRECTION—
Apr 6, 201089AGREGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTEDThe USPTO accepted your combined Section 8 declaration and Section 9 renewal application. The registration is renewed for another 10-year term. The next combined maintenance filing will be due at the following 10-year anniversary.
Mar 31, 2010E89RTEAS SECTION 8 & 9 RECEIVED—
Jul 3, 2006C15AREGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.—
Apr 11, 2006815FREGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED—
Apr 11, 2006E815TEAS SECTION 8 & 15 RECEIVED—
Apr 10, 2006CFITCASE FILE IN TICRS—
Apr 5, 2006ASCKASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY—
Apr 11, 2000R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jan 18, 2000PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Dec 17, 1999NPUBNOTICE OF PUBLICATION—
Sep 21, 1999CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 16, 1999CNEAEXAMINER'S AMENDMENT MAILED—
Mar 30, 1999CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 24, 1999DOCKASSIGNED TO EXAMINER—
Feb 17, 1999DOCKASSIGNED TO EXAMINER—

Frequently asked questions

Related guidance